ChemPartner and Trianni Announce Partnering Agreement

SAN FRANCISCO, Aug. 2, 2016 /PRNewswire/ — Trianni, Inc. (“TRIANNI”) and ChemPartner, a leading science-driven, technologically advanced, high-quality preclinical research partner, today announced an agreement designed to facilitate third-party access to The Trianni...

ShangPharma Congratulates Morphic Therapeutic

July 1, 2016 – SHANGHAI – ShangPharma , a leading China-based pharmaceutical and biotechnology research and development platform company serving healthcare industry, congratulates Morphic Therapeutic for accomplishing $51.5 Million Series A financing to develop...
ChemPartner at CPSA Shanghai 2016

ChemPartner at CPSA Shanghai 2016

The sixth Clinical & Pharmaceutical Solutions through Analysis (CPSA) was successfully held in Renaissance Shanghai Pudong Hotel on April 20th- 22th, 2016. More than 200 people were attracted, who are from multinational pharmaceutical companies, domestic CRO,...
San Diego, April 5-9, 2014, ChemPartner attended AACR.

San Diego, April 5-9, 2014, ChemPartner attended AACR.

The American Association for Cancer Research 2016 Annual Meeting,as one of the most important International tumor conference, was held in New Orleans on Apr 16th -20th .The topic was “Delivering Cures Through Cancer Science”. It is reported that more than 6000...
ChemPartner at the 3rd PEGS CHINA

ChemPartner at the 3rd PEGS CHINA

The third Protein & Antibody Engineering and Development Summit (PEGS CHINA) sponsored by CHI (Cambridge Healthtech Institute)  was held in Shanghai  Pudong  Grand Hyatt  Hotel on Apr 5th, 2016. More than 200 participants from China, the United States, Europe and...